Focusing on the 4th generation DNA sequencing technology, GENVIDA utilizes its globally patented SONAS® platform, a solid-state nanopore sensor array-based technology, to resolve the bottleneck in the DNA sequencing market. By integrating our cross-disciplinary research results in biotechnology, nanofabrication, microfluidics, and bioinformatics, we are ready to kick start the product development plan. Our low-cost SONAS®nanopore sensor array can provide high quality, real-time genomic data to detect the ever-mutating SARS-2 corona virus and to satisfy the high-volume demand in personalized medicine. With our world-class technologies, we can grasp the opportunity in the rapidly expanding biotechnology market.